RESUMO
Most analyses of genital immunity to herpes simplex virus type 2 (HSV-2) have been performed in females, consequently immune protection of the male genital epithelium is incompletely understood. We developed a model of male genital HSV-2 infection resulting from intrarectal inoculation of guinea pigs. Vesicular lesions developed transiently on the perineum and foreskin concurrent with acute virus shedding. Virus shedding and recurrent genital lesions were also detected after establishment of a latent infection. Analysis of perineum and foreskin RNA detected transcripts for IFNγ, proinflammatory and regulatory cytokines, and for genes involved in migration and regulation of leukocytes. HSV-specific T cells were detected in lymphoid and genital tissues after resolution of the primary infection whereas virus-specific antibody secreting cells were detected only in lymphoid tissue. Taken together, the ability to quantify pathogenesis and local immunity in this guinea pig model represent an important advance towards understanding immunity to HSV-2 in males.
Assuntos
Genitália Masculina/imunologia , Genitália Masculina/patologia , Herpes Genital/imunologia , Herpes Genital/patologia , Herpesvirus Humano 2/fisiologia , Animais , Anticorpos Antivirais/imunologia , Citocinas/genética , Modelos Animais de Doenças , Prepúcio do Pênis/imunologia , Prepúcio do Pênis/patologia , Prepúcio do Pênis/virologia , Expressão Gênica , Genitália Masculina/virologia , Cobaias , Herpes Genital/virologia , Herpesvirus Humano 2/imunologia , Masculino , Períneo/patologia , Períneo/virologia , Linfócitos T/imunologia , Linfócitos T/virologia , Eliminação de Partículas ViraisAssuntos
Fissura Anal/virologia , Herpes Simples/diagnóstico , Herpesvirus Humano 2/isolamento & purificação , Leucemia Linfocítica Crônica de Células B/complicações , Idoso , Feminino , Fissura Anal/tratamento farmacológico , Herpes Simples/tratamento farmacológico , Herpes Simples/virologia , Humanos , Períneo/virologiaRESUMO
No disponible
Assuntos
Humanos , Masculino , Adulto , Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Herpes Genital/diagnóstico , Períneo/virologia , Úlcera Cutânea/diagnóstico , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/virologia , Antivirais/uso terapêutico , Herpes Genital/tratamento farmacológico , Herpes Genital/virologia , Herpesvirus Humano 2/isolamento & purificação , Hospedeiro Imunocomprometido , Períneo/patologia , Úlcera Cutânea/tratamento farmacológico , Úlcera Cutânea/virologiaRESUMO
Equine coital exanthema (ECE) is an infectious, venereally transmitted muco-cutaneous disease affecting mares and stallions, caused by equid alphaherpesvirus 3 (EHV3). Diagnostic tools for rapid identification of EHV3 are of primary importance to diminish the risk of EHV3 dissemination at the time of breeding. In the last years, it has been shown that the performance of the insulated-isothermal polymerase chain reaction (iiPCR) is comparable to virus isolation, nested PCR and real-time PCR (qPCR) in detecting pathogens of various animal species. Analytical sensitivity and specificity of the iiPCR were compared with a qPCR, using a plasmid containing the target region of the EHV3 glycoprotein G gene and an Argentinian EHV3 isolate (E/9283/07 C3A). In order to evaluate the diagnostic performance of the iiPCR, nucleic acids of 85 perineal and genital swabs (PGS) of mares and stallions were extracted by tacoTM mini and tested by both techniques. EHV3 was detected in 46 and 45 of the 85 PGS by the iiPCR and qPCR, respectively. There was almost perfect agreement between the two diagnostic methods (98.82%; 95% CI: 95.03-100%; κâ¯=â¯0.98). The iiPCR had a limit of detection of 95.00% at 6 genome equivalents per reaction and a detection endpoint for viral DNA comparable to that of the qPCR, and did not react with six non-targeted equine pathogens. The iiPCR represents a sensitive and specific method for the rapid on-site diagnosis of EHV3 infection. Its routinely implementation in breeding facilities, and artificial insemination and embryo transfer centers, will contribute to prevent the dissemination of this venereal, highly contagious disease in horses.
Assuntos
Genitália/virologia , Infecções por Herpesviridae/veterinária , Herpesvirus Equídeo 3/isolamento & purificação , Doenças dos Cavalos/diagnóstico , Técnicas de Diagnóstico Molecular/métodos , Períneo/virologia , Reação em Cadeia da Polimerase/métodos , Animais , Infecções por Herpesviridae/diagnóstico , Doenças dos Cavalos/virologia , Cavalos , Testes Imediatos , Sensibilidade e EspecificidadeAssuntos
Infecções Oportunistas Relacionadas com a AIDS/diagnóstico , Herpes Genital/diagnóstico , Períneo/virologia , Úlcera Cutânea/diagnóstico , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/virologia , Adulto , Antivirais/uso terapêutico , Herpes Genital/tratamento farmacológico , Herpes Genital/virologia , Herpesvirus Humano 2/isolamento & purificação , Humanos , Hospedeiro Imunocomprometido , Masculino , Períneo/patologia , Úlcera Cutânea/tratamento farmacológico , Úlcera Cutânea/virologia , Valaciclovir/uso terapêuticoRESUMO
BACKGROUND: Chronic HSV infection is a cause of chronic perineal ulcerations. We report a case of a chronic and refractory HSV infection revealing chronic lymphoid leukaemia. PATIENTS AND METHODS: An 85-year-old woman with an 8-month history of chronic perineal ulcerations was referred to our dermatology department. She had no previous medical history of herpes infection. Skin biopsies ruled out carcinoma but were consistent with HSV infection. A local swab was positive for HSV2. Treatment with valaciclovir and intravenous acyclovir (ACV) at the recommended doses was ineffective. Laboratory tests revealed type-B chronic lymphoid leukaemia. Molecular biology studies confirmed the presence of ACV-resistant HSV via decreased thymidine kinase activity (stop codon: M183stop). Foscarnet was administered for a period of 3 weeks with almost complete healing of the ulcerations. Treatment was stopped prematurely due to acute renal insufficiency and the remaining lesions were treated using imiquimod cream. Valaciclovir was prescribed to prevent further episodes. The condition recurred a mere 11 months later. DISCUSSION: The prevalence of ACV-resistant HSV is 0.32 % in immunocompetent patients and 3.5 % in immunocompromised patients. Insufficient dosing regimens or prolonged treatment with TK inhibitors result in the local selection of pre-existing mutant HSV viruses. Foscarnet, a DNA polymerase inhibitor, is the treatment of choice in HSV-resistant infections. ACV-resistant HSV is less virulent and replicates less, with reactivations being mainly due to wild-type HSV latent in the neural ganglia. Valaciclovir can be used as a preventive treatment. To our knowledge, this is the first case of ACV-resistant HSV infection revealing chronic lymphoid leukaemia. CONCLUSION: Chronic perineal ulcerations can be the first manifestation of immunodeficiency seen for example with haematological diseases. In the event of clinical resistance of an HSV infection to recommended thymidine kinase inhibitor regimens, the use of foscarnet should be considered.
Assuntos
Aciclovir , Antivirais , Foscarnet/uso terapêutico , Herpes Simples/complicações , Hospedeiro Imunocomprometido , Leucemia Linfocítica Crônica de Células B/tratamento farmacológico , Aciclovir/administração & dosagem , Adjuvantes Imunológicos/administração & dosagem , Administração Cutânea , Idoso de 80 Anos ou mais , Aminoquinolinas/administração & dosagem , Antivirais/administração & dosagem , Feminino , Herpes Simples/tratamento farmacológico , Humanos , Imiquimode , Períneo/patologia , Períneo/virologiaRESUMO
Human papillomavirus (HPV) is found in adults and adolescents and is associated with genital warts and cervical cancer. However, it has been detected in girls younger than 10 years old. Currently, there are no prevention methods for this age group, since it is not considered a risk group. The aim of this study was to evaluate the presence of infection and HPV subtype in girls under 9 years old attended at a referral service in the State of Espírito Santo, Brazil. Forty-three girls younger than 9 years old had gynecological brush samples collected from vulval and perineal/anal regions. Viral detection and subtyping were done using polymerase chain reaction, restriction fragment length polymorphism and DNA sequencing. Statistics was performed using Action Stat 3.1. The mean age of girls was 6.1 years. Sexual activity and abuse were not reported by 95.3%. Family stories showed viral infection in 9.3% of mothers, 4.7% of fathers and 9.3% of caretakers. None of these were related with the children infection. In the only case of mother's gestational HPV infection, the daughter tested negative. Genital warts and infection were observed in 7% and 13.9% of the patients, respectively. Viral subtypes detected were 6, 11, 38, and 42. These results demonstrate the presence of HPV infection in girls under 9 years of age. Prevalence studies are needed in order to evaluate a possible alteration in age of vaccination policy.
Assuntos
Papillomaviridae/classificação , Papillomaviridae/isolamento & purificação , Infecções por Papillomavirus/epidemiologia , Brasil/epidemiologia , Criança , Pré-Escolar , Estudos Transversais , Feminino , Técnicas de Genotipagem , Humanos , Lactente , Recém-Nascido , Papillomaviridae/genética , Períneo/virologia , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Prevalência , Análise de Sequência de DNA , Vulva/virologiaAssuntos
Canal Anal/virologia , Herpes Zoster/virologia , Períneo/virologia , Aciclovir/uso terapêutico , Canal Anal/patologia , Antivirais/uso terapêutico , Criança , Herpes Zoster/tratamento farmacológico , Herpes Zoster/patologia , Humanos , Masculino , Períneo/patologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaçõesRESUMO
INTRODUCTION: Human papillomavirus (HPV) infection is a cause of premalignant and malignant cancer in the lower genital and digestive tracts. In Brazil, there have been no prevalence studies that included a nationwide sample, and the prevalence of HPV has not been determined in many regions. METHODS: We will search the EMBASE, LILACS, MEDLINE, Web of Science and SciELO databases and previously published review articles to identify original research articles assessing HPV prevalence of the perineal (cervical, penile and anal) and oral areas. No exclusion criteria related to language or publication date will apply. 2 reviewers will independently screen for eligibility and perform data extraction. Discrepancies will be resolved through consensus; the opinion of a third reviewer will be sought as necessary. Relevant measures and data about study and population characteristics will be extracted from the included studies. Where possible, study prevalence will be pooled using a random-effects meta-analysis. The methodological quality of the studies will be assessed using an adapted version of the NIH 'Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies'. The overall quality of evidence will be assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE). ETHICS AND DISSEMINATION: We expect to estimate the prevalence of perineal and oral HPV infection in the general population as well as the prevalence of HPV infection in individuals with premalignant and malignant lesions in Brazil and its 5 geographic regions. This systematic review does not require ethical approval. TRIAL REGISTRATION NUMBER: CRD42016032751.
Assuntos
Papillomaviridae/isolamento & purificação , Infecções por Papillomavirus/epidemiologia , Brasil/epidemiologia , Estudos Transversais , Humanos , Boca/virologia , Períneo/virologia , Lesões Pré-Cancerosas/virologia , Prevalência , Revisões Sistemáticas como AssuntoRESUMO
BACKGROUND: In this analysis, we examine the incidence and clearance of external genital human papillomavirus (HPV) infection among heterosexual males aged 16-24 years. METHODS: A total of 1732 males aged 16-24 years old in the placebo arm of a quadrivalent HPV vaccine trial were included in this analysis. Participants were enrolled from 18 countries in Africa, the Asia-Pacific region, Europe, Latin America, and North America. Subjects underwent anogenital examinations and sampling of the penis, scrotum, and perineal/perianal regions. RESULTS: The incidence rate of any HPV DNA genotype 6, 11, 16, and/or 18 detection was 9.0 cases per 100 person-years. Rates of HPV DNA detection were highest in men from Africa. Median time to clearance of HPV genotypes 6, 11, 16, and 18 DNA was 6.1, 6.1, 7.7, and 6.2 months, respectively. Median time to clearance of persistently detected HPV 6, 11, 16, and 18 DNA was 6.7, 3.2, 9.2, and 4.7 months, respectively. CONCLUSION: The study results suggest that the acquisition of HPV 6, 11, 16, and/or 18 in males is common and that many of these so-called infections are subsequently cleared, similar to findings for women. Nevertheless, given the high rate of HPV detection among young men, HPV vaccination of males may reduce infection in men and reduce the overall burden of HPV-associated disease in the community.
Assuntos
Condiloma Acuminado/epidemiologia , Neoplasias dos Genitais Masculinos/epidemiologia , Heterossexualidade , Papillomaviridae/isolamento & purificação , Infecções por Papillomavirus/epidemiologia , Adolescente , Condiloma Acuminado/complicações , DNA Viral/genética , DNA Viral/isolamento & purificação , Progressão da Doença , Feminino , Genótipo , Saúde Global , Humanos , Incidência , Masculino , Papillomaviridae/classificação , Papillomaviridae/genética , Pênis/patologia , Pênis/virologia , Períneo/patologia , Períneo/virologia , Escroto/patologia , Escroto/virologia , Adulto JovemRESUMO
Verrucous carcinoma of the perianal area continues still to be rare finding, which in histopathological aspect is a highly differentiated form of squamous cell carcinoma. Many literature data show that it is quite possible that HPV viruses play probably a key role in the etiology of verrucous carcinoma. We present a case of 48 year-old female patient with verrucous carcinoma localized in the perianal area, treated initially under the diagnosis of perianal skin tags, while surgical removal of the lesion was found rare form of HPV associated verrucous carcinoma. A preventive mono-chemotherapy with methotrexate by scheme was started for an initial period of 3 months. Six months later, the provided monitoring has not shown clinical or apparative data on tumor recurrence. The article discusses key points of the diagnostic algorithm in patients with HPV associated lesions with anogenital localization and provides valuable recommendations for correct clinical behavior in these risk groups.
Assuntos
Antimetabólitos Antineoplásicos/uso terapêutico , Carcinoma Verrucoso/terapia , Carcinoma Verrucoso/virologia , Metotrexato/uso terapêutico , Papillomaviridae/isolamento & purificação , Neoplasias Cutâneas/terapia , Neoplasias Cutâneas/virologia , Carcinoma Verrucoso/tratamento farmacológico , Carcinoma Verrucoso/cirurgia , Procedimentos Cirúrgicos Dermatológicos , Feminino , Humanos , Pessoa de Meia-Idade , Períneo/patologia , Períneo/cirurgia , Períneo/virologia , Período Pós-Operatório , Indução de Remissão , Pele/efeitos dos fármacos , Pele/patologia , Pele/virologia , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/cirurgiaRESUMO
The clinical and histopathological features of cutaneous herpes simplex virus (HSV) infection have been well described. Genital herpetic infections are largely induced by HSV type 2, but 30% of cases can be caused by HSV type 1. Immunocompromised patients are known to exhibit atypical patterns of clinical presentation with variable lesion morphology and anatomic location. A subset of patients may show morphology such as nodules or verrucous lesions. Analogously, some biopsy specimens may show unusual microscopical features, such as a lack of keratinocyte cytopathology, lymphocyte infiltration or vasculopathic changes that are expected irrespective of the patient's immune status. We present the case of a patient carrying a previous diagnosis of pemphigus vulgaris, status posttreatment with methotrexate and prednisone, who developed a perineal ulcer exhibiting significant numbers of plasma cells, many of which were cytologically atypical. This morphology was suggestive of a hematopoietic malignancy. Immunoperoxidase staining for HSV decorated a focal collection of keratinocytes that lacked appreciable viral changes expected of HSV infection.
Assuntos
Herpes Simples/patologia , Plasmócitos/patologia , Dermatopatias/patologia , Pele/patologia , Úlcera/patologia , Aciclovir/administração & dosagem , Aciclovir/análogos & derivados , Adulto , Antivirais/administração & dosagem , Fármacos Dermatológicos/administração & dosagem , Fármacos Dermatológicos/efeitos adversos , Feminino , Herpes Simples/induzido quimicamente , Herpes Simples/tratamento farmacológico , Herpes Simples/virologia , Herpesvirus Humano 1 , Herpesvirus Humano 2 , Humanos , Metotrexato/administração & dosagem , Metotrexato/efeitos adversos , Pênfigo/tratamento farmacológico , Pênfigo/patologia , Pênfigo/virologia , Períneo/patologia , Períneo/virologia , Prednisolona/administração & dosagem , Prednisolona/efeitos adversos , Pele/metabolismo , Dermatopatias/virologia , Úlcera/induzido quimicamente , Úlcera/virologia , Valaciclovir , Valina/administração & dosagem , Valina/análogos & derivadosAssuntos
Infecções por Citomegalovirus/complicações , Fissura Anal/etiologia , Fissura Anal/virologia , Trombose/virologia , Antivirais/administração & dosagem , Núcleo Celular/virologia , Infecções por Citomegalovirus/patologia , Feminino , Fissura Anal/patologia , Ganciclovir/administração & dosagem , Ganciclovir/análogos & derivados , Humanos , Hospedeiro Imunocomprometido , Imuno-Histoquímica , Transplante de Fígado , Pessoa de Meia-Idade , Períneo/virologia , Pele/irrigação sanguínea , Pele/virologia , ValganciclovirRESUMO
BACKGROUND: We examined the baseline prevalence of penile, scrotal, and perineal/perianal human papillomavirus (HPV) in heterosexual men (HM). We also evaluated baseline characteristics of HM to assess factors associated with prevalent HPV detection. METHODS: We tested serum samples from 3463 HM aged 16-24 years with 1-5 lifetime female sexual partners for antibodies to HPV 6, 11, 16, and 18. We collected baseline swab specimens for the detection of DNA of HPV 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59 from 3 areas: penile, scrotal, and perineal/perianal. Risk factors for prevalent HPV DNA detection were evaluated. RESULTS: The prevalence of any tested HPV type was 18.7% at the penis, 13.1% at the scrotum, 7.9% at the perineal/perianal region, and 21.0% at any site. Having >3 lifetime female sexual partners had the greatest impact on HPV prevalence: odds ratio (OR) 3.2 (95% confidence interval (CI) 2.1-4.9) for HPV 6, 11, 16, and 18; and OR 4.5 (95% CI 3.3-6.1) for all HPV types tested. HPV DNA detection was highest in Africa. Neither condom usage nor circumcision was associated with HPV DNA prevalence. CONCLUSION: Genital-HPV DNA detection is common in young, sexually active HM. We found HPV to be most prevalent in African men and least prevalent in men from the Asia-Pacific region. Increased numbers of sexual partners was an important risk factor for HPV DNA prevalence.
Assuntos
Doenças dos Genitais Masculinos/epidemiologia , Heterossexualidade , Papillomaviridae/isolamento & purificação , Infecções por Papillomavirus/epidemiologia , Adolescente , Adulto , Canal Anal/virologia , Anticorpos Antivirais/sangue , DNA Viral/genética , DNA Viral/isolamento & purificação , Doenças dos Genitais Masculinos/virologia , Humanos , Masculino , Papillomaviridae/classificação , Papillomaviridae/genética , Infecções por Papillomavirus/virologia , Pênis/virologia , Períneo/virologia , Prevalência , Fatores de Risco , Escroto/virologia , Adulto JovemRESUMO
BACKGROUND: We examined the baseline prevalence of penile, scrotal, perineal/perianal, and intra-anal human papillomavirus (HPV) infection in human immunodeficiency virus (HIV)-seronegative men who have sex with men (MSM). METHODS: Data were analyzed from 602 MSM aged 16-27 years with ≤ 5 lifetime sexual partners. Serum samples were tested for antibodies to HPV6/11/16/18. Swab samples were collected separately from several anogenital areas for detection of HPV6/11/16/18/31/33/35/39/45/51/52/56/58/59 DNA. RESULTS: The prevalence of any tested HPV type was 18.5% at the penis, 17.1% at the scrotum, 33.0% at the perineal/perianal region, 42.4% in the anal canal, and 48.0% at any site. Overall, 415 MSM (69.7%) were negative to HPV 6, 11, 16, and 18 at enrollment by both serology and DNA detection. Men residing in Europe and Latin America had significantly increased risk of HPV infection at external genital sites and the anal canal compared to men from Australia. Tobacco use and greater number of lifetime sexual partners was associated with higher HPV infection prevalence. CONCLUSIONS: The prevalence of HPV infection is high among young sexually active MSM, with the anal canal being the most common site of infection. Lifetime number of sexual partners was the most important modifiable risk factor for anogenital HPV infection.
Assuntos
Doenças do Ânus/epidemiologia , Doenças dos Genitais Masculinos/epidemiologia , Homossexualidade Masculina , Papillomaviridae/isolamento & purificação , Infecções por Papillomavirus/epidemiologia , Adolescente , Adulto , Canal Anal/virologia , Anticorpos Antivirais/sangue , Doenças do Ânus/virologia , Austrália , DNA Viral/genética , DNA Viral/isolamento & purificação , Europa (Continente) , Doenças dos Genitais Masculinos/virologia , Humanos , América Latina , Masculino , Papillomaviridae/classificação , Papillomaviridae/genética , Infecções por Papillomavirus/virologia , Pênis/virologia , Períneo/virologia , Prevalência , Fatores de Risco , Escroto/virologia , Adulto JovemAssuntos
Condiloma Acuminado/patologia , Infecções por Papillomavirus/patologia , Períneo/patologia , Condiloma Acuminado/diagnóstico , Condiloma Acuminado/cirurgia , Condiloma Acuminado/virologia , Papillomavirus Humano 11/isolamento & purificação , Papillomavirus Humano 6/isolamento & purificação , Humanos , Lactente , Transmissão Vertical de Doenças Infecciosas , Masculino , Infecções por Papillomavirus/diagnóstico , Infecções por Papillomavirus/cirurgia , Infecções por Papillomavirus/virologia , Períneo/cirurgia , Períneo/virologiaRESUMO
HPV testing is a valuable tool in cervical cancer screening and efficacy assessment of HPV vaccines. Concordance of specimens from three sites for detection of HPV DNA in the female genital tract was evaluated. At a single visit, the following specimens were collected: an endo-ecto-cervical swab (EEC), labial/vulvar/perineal/perianal swab (LVPP) and cervicovaginal lavage (CVL). Specimens were evaluated with HPV6, HPV11, HPV16, and HPV18 type- and gene-specific PCR assays. Of the 898 women evaluated at baseline, 232 were HPV PCR positive in at least one specimen. Of these, for HPV6, HPV11, HPV16, and HPV18, respectively, throughout: (a) 70.4%, 40.0%, 65.3%, and 64.1% tested three-site positive; (b) 13.6%, 30.0%, 19.7%, and 18.8% tested two-site positive; and (c) 16.4%, 30.0%, 15.0%, and 17.2% tested single-site positive. For patients who tested single-site positive for HPV6, HPV11, HPV16, or HPV18, respectively, the specimen was: LVPP in 92.3%, 33.3%, 68.2%, and 72.7%; EEC in 0.0%, 33.3%, 18.2%, and 9.1%; and CVL in 7.7%, 33.3%, 13.6%, and 18.2%. Combining results of swab specimens together increases detection of HPV6, HPV11, HPV16, and HPV 18, respectively, to 98.7%, 90.0%, 97.9%, and 96.9%. HPV DNA is detectable from all three sites using type-specific PCR assays; most women who tested positive for a given HPV type were positive for that type in all three specimens.
Assuntos
DNA Viral/isolamento & purificação , Genitália Feminina/virologia , Papillomaviridae/isolamento & purificação , Infecções por Papillomavirus/diagnóstico , Manejo de Espécimes/métodos , Adolescente , Colo do Útero/virologia , Feminino , Humanos , Períneo/virologia , Vagina/virologia , Vulva/virologia , Adulto JovemRESUMO
The purpose was to study the perinatal transmission of human papillomavirus DNA (HPV-DNA) in 63 mother-newborn pairs, besides looking at the epidemiological factors involved in the viral DNA transmission. The following sampling methods were used: (1) in the pregnant woman, when was recruited, in cervix and clinical lesions of the vagina, vulva and perineal region; (2) in the newborn, (a) buccal, axillary and inguinal regions; (b) nasopharyngeal aspirate, and (c) cord blood; (3) in the children, buccal was repeated in the 4th week and 6th and 12th month of life. HPV-DNA was identified using two methodologies: multiplex PCR (PGMY09 and MY11 primers) and nested-PCR (genotypes 6/11, 16, 18, 31, 33, 42, 52 and 58). Perinatal transmission was considered when concordance was found in type-specific HPV between mother/newborn or mother/child. HPV-DNA genital was detected in 49 pregnant women submitted to delivery. Eleven newborns (22.4%, n = 11/49) were HPV-DNA positive. In 8 cases (16.3%, n = 8/49) there was type specific HPV concordance between mother/newborn samples. At the end of the first month of life three children (6.1%, n = 3/49) became HPV-DNA positive, while two remained positive from birth. In 3 cases (100%, n = 3/3) there was type specific HPV concordance between mother/newborn samples. In the 6th month, a child (2%, n = 1/49) had become HPV-DNA positive between the 1st and 6th month of life, and there was type specific HPV concordance of mother/newborn samples. All the HPV-DNA positive children (22.4%, n = 11/49) at birth and at the end first month of life (6.1%, n = 3/49) became HPV-DNA negative at the age of 6 months. The HPV-DNA positive child (2%, n = 1/49) from 1st to the 6th month of life became HPV-DNA negative between the 6th and 12th month of life and one child had anogenital warts. In the twelfth month all (100%, n = 49/49) the children studied were HPV-DNA negative. A positive and significant correlation was observed between perinatal transmission of HPV-DNA and the immunodepression of maternal variables (HIV, p = 0.007). Finally, the study suggests that perinatal transmission of HPV-DNA occurred in 24.5% (n = 12/49) of the cases studied.